Hepatitis C And Hepatocarcinoma: Response And Treatment | 3512
Journal of Gastrointestinal & Digestive System
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Liver disease is a general term for any damage that reduces the functioning of the liver. The prevalence of hepatitis C virus
(HCV) infection varies across the world, with the highest number reported in Egypt. HCV infects liver and may lead to hepatocellular
The assessment of new strategies for response and treatment of HCV and HCC is the broad objective of this work.
Material & Methods:
Quantification of HCV-RNA by qRT-PCR was performed for every patient. Gene polymorphisms of Bcl-2
(Ala43Thr) using PCR-RFLP and GH levels using ELISA were tested. On the other hand, infected Huh-7 cells were transfected with the
SiRNAs targeting the viral genome.
HCV patients have high significant differences of Bcl-2 43Thr genotype and GH levels when comparing non-responders with
responders. There were high significant differences, in the levels of cell density, γ-IFN, CD4, and CD8, when comparing control cultured
cells with curcumin and taurine treated cultured cells.
We concluded that Bcl-2 gene and GH levels can be used as sensitive biomarkers for HCV response to IFN therapy and
suggested that curcumin and taurine can be used in combination with standard therapeutic lines for hepatoma treatment.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals